A randomized single-blind trial of the therapeutic effects and safety of halved dose antipsychotics for treating relapse in patients with schizophrenia receiving high dose antipsychotic therapy - Trial UMIN000047785
Access comprehensive clinical trial information for UMIN000047785 through Pure Global AI's free database. This phase not specified trial is sponsored by Showa University and is currently Completed. The study focuses on schizophrenia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000047785
Completed
drug
Trial Details
University Hospital Medical Information Network • UMIN000047785
A randomized single-blind trial of the therapeutic effects and safety of halved dose antipsychotics for treating relapse in patients with schizophrenia receiving high dose antipsychotic therapy
Halved dose of antipsychotics versus symptomatic treatment for relapse in patients with schizophrenia receiving high dose antipsychotic therapy: a randomized single blind trial
Study Focus
Sponsor & Location
Showa University
Japan
Timeline & Enrollment
N/A
Jan 04, 2021
N/A
ICD-10 Classifications
Schizophrenia
Simple schizophrenia
Schizophrenia, unspecified
Other schizophrenia
Paranoid schizophrenia
Data Source
University Hospital Medical Information Network
UMIN000047785
Non-Device Trial